Tuesday Feb 25
VIVUS, Inc. Reports Fourth Quarter And Year-End 2013 Financial Results
VIVUS, Inc. , a biopharmaceutical company commercializing QsymiaA capsules CIV for the treatment of obesity, today provided a business update and reported its financial results for the fourth quarter and year ended December 31, 2013.
Mon Feb 17, 2014
Weight loss drugs' side effects worrisome, doctors say
Two drugs approved in 2012 to treat obesity have hardly become big sellers. That's partly because of the cost and spotty insurance coverage.
Fri Feb 14, 2014
Adipex Diet Pills- Right Way to Reduce Your Weight
Adipex diet pills are the one which helps in solving your overweight problem. Though there were number of weight loss treat available in these day markets Arizona February 15, 2014 - Adipex diet pills are the one which helps in solving your overweight problem.
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2014
This increase is attributed to the combination of revenues being generated from an expanding product line, with three new products being launched this year so far, and strong year on year growth of Elite's Phentermine tablets, Hydromorphone and contract manufactured Methadone products launched in prior years.
Wed Feb 12, 2014
The Motley Fool
Can These Obesity Drug Stocks Bounce Back in 2014?
Here's some good news -- America isn't the most obese nation in the world. The bad news is that America still ranks second behind Mexico, according to a United Nations report last July.
Weight Loss: Sorry, Still No Magic Pill And Approved Drugs May Be Dangerous
Since most people don't want to engage in the only weight loss plan guaranteed to work - consuming fewer calories than they burn - options are limited in America's battle of the bulge and are likely to stay limited.
Tue Feb 11, 2014
Jury still out on efficacy of weight-loss drugs - Indiatalkies.com
Washington, Feb. 12: The Federal Drug Administration approved two drugs for long-term weight loss, but researchers from the Dartmouth Institute for Health Policy and Clinical Practice are now questioning their safety after one-year trials.
Mon Feb 10, 2014
Caution Urged Over Weight-Loss Drugs
People should be cautions about using two new weight-loss drugs because it's not clear whether they increase the risk for heart problems, some doctors argue.